STOCK TITAN

Vertex to Announce Second Quarter 2024 Financial Results on August 1

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Vertex Pharmaceuticals (Nasdaq: VRTX) will announce its second quarter 2024 financial results on August 1, 2024, after market close. A conference call and webcast will be held at 4:30 p.m. ET to discuss the results.

U.S. participants can dial (833) 630-2124, while international participants can call +1 (412) 317-0651, referencing the “Vertex Pharmaceuticals Second Quarter 2024 Earnings Call.” The webcast will be accessible via Vertex's website in the 'Investors' section, with an archived version available post-call.

Positive
  • None.
Negative
  • None.

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2024 financial results on Thursday, August 1, 2024 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the “Vertex Pharmaceuticals Second Quarter 2024 Earnings Call.”

The conference call will be webcast live and a link to the webcast can be accessed through Vertex's website at www.vrtx.com in the "Investors" section. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the company's website.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.

Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 14 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on LinkedIn, Facebook, Instagram, YouTube and Twitter/X.

(VRTX-WEB)

Vertex Pharmaceuticals Incorporated Investor Relations:

investorinfo@vrtx.com

Source: Vertex Pharmaceuticals Incorporated

FAQ

When will Vertex Pharmaceuticals report its Q2 2024 financial results?

Vertex Pharmaceuticals will report its second quarter 2024 financial results on August 1, 2024, after the financial markets close.

How can I access Vertex Pharmaceuticals' Q2 2024 earnings call?

You can access Vertex's Q2 2024 earnings call by dialing (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and referencing the “Vertex Pharmaceuticals Second Quarter 2024 Earnings Call.”

Where can I find the webcast for Vertex Pharmaceuticals' Q2 2024 earnings call?

The webcast for Vertex Pharmaceuticals' Q2 2024 earnings call will be available on the company's website in the 'Investors' section.

What time is Vertex Pharmaceuticals' Q2 2024 earnings call?

Vertex Pharmaceuticals' Q2 2024 earnings call is scheduled for 4:30 p.m. ET on August 1, 2024.

Will an archived webcast of Vertex Pharmaceuticals' Q2 2024 earnings call be available?

Yes, an archived webcast of Vertex Pharmaceuticals' Q2 2024 earnings call will be available on the company's website.

Vertex Pharmaceuticals Inc

NASDAQ:VRTX

VRTX Rankings

VRTX Latest News

VRTX Stock Data

126.73B
257.53M
0.09%
95.96%
1.66%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BOSTON